Neuro-co-cardiological DiseasesPost-cardiac Surgery Cerebrovascular DiseasesVascular Lesion
Investigational drug(s) / intervention(s)
Interventional or surgical treatmentInterventional or surgical treatment
Interventional or surgical treatment: Simultaneous interventional or surgical treatment/staged interventional or surgical treatment
Interventional or surgical treatment: Interventional or surgical treatment
Study summary
The objective of this observational cohort study is to evaluate the clinical outcomes of various treatment strategies for cerebrovascular and cardiovascular diseases. Furthermore, it aims to investigate the factors that influence adverse outcomes from these treatments.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
1. Age ≥18 years;
2. Patients with neuro-co-cardiological diseases or post-cardiac surgery cerebrovascular diseases.
Exclusion Criteria:
1. The expected survival is less than 1 years;
2. Simultaneously merge other serious diseases;
Primary outcome measure(s)
Modified Rankin Scale Score — 90±7 days Modified Rankin Scale（0-6）, A lower MRS score indicates better functional status for the patient.
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.